127 related articles for article (PubMed ID: 27979851)
1. Melphalan-induced cardiotoxicity: ventricular arrhythmias.
Yanamandra U; Gupta S; Khadwal A; Malhotra P
BMJ Case Rep; 2016 Dec; 2016():. PubMed ID: 27979851
[No Abstract] [Full Text] [Related]
2. [Cutaneous plasmacytomas following treatment of IgA kappa multiple myeloma].
Ortín X; Llorente A; Martínez S; Ugarriza A
Med Clin (Barc); 2004 Oct; 123(15):597-8. PubMed ID: 15535948
[No Abstract] [Full Text] [Related]
3. Complex hypodiploid acute myeloid leukaemia secondary to chemotherapy for hyperdiploid multiple myeloma.
Mohamed M; Dun K
Int J Hematol; 2014 Jul; 100(1):3-6. PubMed ID: 24820637
[No Abstract] [Full Text] [Related]
4. Melflufen: A Next-Generation Nitrogen Mustard.
Holstein SA; Hillengass J; McCarthy PL
J Clin Oncol; 2021 Mar; 39(7):836-839. PubMed ID: 33439689
[No Abstract] [Full Text] [Related]
5. Melphalan hydrochloride for the treatment of multiple myeloma.
Esma F; Salvini M; Troia R; Boccadoro M; Larocca A; Pautasso C
Expert Opin Pharmacother; 2017 Aug; 18(11):1127-1136. PubMed ID: 28658983
[TBL] [Abstract][Full Text] [Related]
6. [Gynecomastia appearing during myeloma: role of melphalan?].
Cohen JD; Fulpin J; Chouc PY; Jeandel P
Presse Med; 2000 Nov; 29(35):1936. PubMed ID: 11244624
[No Abstract] [Full Text] [Related]
7. Stem cell mobilization in heavily pretreated multiple myeloma patients with prior high dose melphalan and auto-SCT.
Khaled Y; Al-Hazzouri A; Mizrachi A; Reynolds R; Reddy V; Solh M
Bone Marrow Transplant; 2013 Feb; 48(2):310-1. PubMed ID: 22773127
[No Abstract] [Full Text] [Related]
8. Melphalan Flufenamide (Melflufen): First Approval.
Dhillon S
Drugs; 2021 Jun; 81(8):963-969. PubMed ID: 33961277
[TBL] [Abstract][Full Text] [Related]
9. Flip-flop ventricular tachycardia.
Tomcsányi J; Wettstein A; Frész T
J Cardiovasc Electrophysiol; 2014 Aug; 25(8):908-909. PubMed ID: 24654908
[No Abstract] [Full Text] [Related]
10. Gelatinous transformation of bone marrow following chemotherapy for myeloma.
Mathew M; Mathews I; Manohar C; Rao S
Indian J Pathol Microbiol; 2001 Jan; 44(1):53-4. PubMed ID: 12561997
[TBL] [Abstract][Full Text] [Related]
11. Cryotherapy for the prevention of high-dose melphalan-induced oral mucositis.
Mori T; Aisa Y; Yamazaki R; Mihara A; Ikeda Y; Okamoto S
Bone Marrow Transplant; 2006 Nov; 38(9):637-8. PubMed ID: 16953203
[No Abstract] [Full Text] [Related]
12. Melphalan and its role in the management of patients with multiple myeloma.
Falco P; Bringhen S; Avonto I; Gay F; Morabito F; Boccadoro M; Palumbo A
Expert Rev Anticancer Ther; 2007 Jul; 7(7):945-57. PubMed ID: 17627453
[TBL] [Abstract][Full Text] [Related]
13. Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myeloma.
Moreau P; Fiere D; Bezwoda WR; Facon T; Attal M; Laporte JP; Colombat P; Haak HL; Monconduit M; Lockhorst H; Girault D; Harousseau JL
J Clin Oncol; 1997 Feb; 15(2):660-6. PubMed ID: 9053491
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of melphalan, arsenic trioxide, and ascorbic acid combination therapy (MAC) in relapsed and refractory multiple myeloma.
Borad MJ; Swift R; Berenson JR
Leukemia; 2005 Jan; 19(1):154-6. PubMed ID: 15496977
[No Abstract] [Full Text] [Related]
15. Melphalan kinetics in hyperthermic isolation perfusion of the extremities.
Loos U; Musch E; Rauschecker H; Willenbrock C
J Chemother; 1989 Jul; 1(4 Suppl):1246-7. PubMed ID: 16312851
[No Abstract] [Full Text] [Related]
16. 200 mg/m(2) melphalan--the gold standard for multiple myeloma.
Giralt S
Nat Rev Clin Oncol; 2010 Sep; 7(9):490-1. PubMed ID: 20798699
[No Abstract] [Full Text] [Related]
17. "Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma.
Gasparetto C; Gockerman JP; Diehl LF; de Castro CM; Moore JO; Long GD; Horwitz ME; Keogh G; Chute JP; Sullivan KM; Neuwirth R; Davis PH; Sutton LM; Anderson RD; Chao NJ; Rizzieri D
Biol Blood Marrow Transplant; 2010 Jan; 16(1):70-7. PubMed ID: 19733251
[TBL] [Abstract][Full Text] [Related]
18. Progress in the treatment of multiple myeloma.
Kumar S
Lancet; 2006 Mar; 367(9513):791-2. PubMed ID: 16530557
[No Abstract] [Full Text] [Related]
19. Further progress in the treatment of multiple myeloma?
Malik PS; Kumar L
Natl Med J India; 2009; 22(1):25-7. PubMed ID: 19761157
[No Abstract] [Full Text] [Related]
20. Unusual Incessant Ventricular Tachycardia: What Is the Underlying Cause and the Possible Mechanism?
Shenthar J
Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1507-11. PubMed ID: 26671936
[No Abstract] [Full Text] [Related]
[Next] [New Search]
